Schwaninger group

Gene regulation in cerebral ischemia

Schwaninger

Markus Schwaninger

Institut für Experimentelle und Klinische Pharmakologie und Toxikologie
Universität of Lübeck
Ratzeburger Allee 160
23538 Lübeck
Germany

Phone:  +49-451-5002681
Fax:  +49-451-5003327
Email:  markus.schwaninger@pharma.uni-luebeck.de
Website:  http://www.pharma.uni-luebeck.de/Home/direktor.html

Research Summary

Stroke is a common and devastating disorder but still there is no effective therapy for the majority of patients. Because delayed mechanisms of ischemic brain damage such as neuroinflammation, apoptosis, and neurogenesis, rely on gene expression, we investigate gene regulation in the context of cerebral ischemia. Genetic and pharmacological tools are combined with the long-term aim to improve stroke therapy.

Structure of the Group

Group Leader:  Markus Schwaninger
   
Postdoctoral fellows:  Dirk Ridder, Antje Krenz
PhD-Students:  Waleed Barakat, Christoph Leib, Ming-Fei Lang, Sasidhar Murikinati, Melanie Neubert, Lars Werner
Technicians:  Nadine Gehrig, Ira Maegele, Christina Stannek
Editor: Email
Latest Revision: 2012-09-11
zum Seitenanfang/up